MYC and colorectal cancer: This confirms the potential of LINRIS-IGF2BP2-MYC axis for colorectal cancer targeted therapy (80); LncRNA LINC00460 interacts with IGF2BP2 and DHX9 to form the LINC00460/DHX9/IGF2BP2 complex.